comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - rokotteet - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. käyttö tämä rokote tulee virallisten suositusten mukaisesti.
human igg1 monoclonal antibody specific for human interleukin-1 alpha xbiotech
xbiotech germany gmbh - humaani iggl-monoklonaalinen vasta-aine, joka on spesifinen ihmisen interleukiini-1-alfalle - paksusuolen vajaatoiminta - antineoplastiset aineet - metastasoituneen paksu-ja peräsuolen syöpä.
frontect 2-5 kg:n painoisille koirille paikallisvaleluliuos
boehringer ingelheim animal health nordics a/s - fipronilum,permethrinum - paikallisvaleluliuos - fiproniili, yhdistelmävalmisteet
frontect 5-10 kg:n painoisille koirille paikallisvaleluliuos
boehringer ingelheim animal health nordics a/s - permethrinum,fipronilum - paikallisvaleluliuos - fiproniili, yhdistelmävalmisteet
frontect 20-40 kg:n painoisille koirille paikallisvaleluliuos
boehringer ingelheim animal health nordics a/s - permethrinum,fipronilum - paikallisvaleluliuos - fiproniili, yhdistelmävalmisteet
frontect 10-20 kg:n painoisille koirille paikallisvaleluliuos
boehringer ingelheim animal health nordics a/s - fipronilum,permethrinum - paikallisvaleluliuos - fiproniili, yhdistelmävalmisteet
frontect 40-60 kg:n painoisille koirille paikallisvaleluliuos
boehringer ingelheim animal health nordics a/s - fipronilum,permethrinum - paikallisvaleluliuos - fiproniili, yhdistelmävalmisteet
frontect paikallisvaleluliuos
boehringer ingelheim animal health nordics a/s - permethrin, fipronil - paikallisvaleluliuos - fiproniili
frontect paikallisvaleluliuos
boehringer ingelheim animal health nordics a/s - permethrin, fipronil - paikallisvaleluliuos - fiproniili
frontect paikallisvaleluliuos
boehringer ingelheim animal health nordics a/s - permethrin, fipronil - paikallisvaleluliuos - fiproniili